AAAAAA

   
Results: 1-15 |
Results: 15
INTRACELLULAR AND SERUM STABILITY OF LIPOSOMAL 2',3'-DIDEOXYCYTIDINE - EFFECT OF LIPID-COMPOSITION
Authors: MAKABIPANZU B GOURDE P DESORMEAUX A BERGERON MG
Citation: B. Makabipanzu et al., INTRACELLULAR AND SERUM STABILITY OF LIPOSOMAL 2',3'-DIDEOXYCYTIDINE - EFFECT OF LIPID-COMPOSITION, Cellular and molecular biology, 44(2), 1998, pp. 277-284
EPSTEIN-BARR-VIRUS INFECTS AND INDUCES APOPTOSIS IN HUMAN NEUTROPHILS
Authors: LAROCHELLE B FLAMAND L GOURDE P BEAUCHAMP D GOSSELIN J
Citation: B. Larochelle et al., EPSTEIN-BARR-VIRUS INFECTS AND INDUCES APOPTOSIS IN HUMAN NEUTROPHILS, Blood, 92(1), 1998, pp. 291-299
TIME-RESTRICTED FEEDING SCHEDULES MODIFY TEMPORAL VARIATION OF GENTAMICIN EXPERIMENTAL NEPHROTOXICITY
Authors: BEAUCHAMP D GUIMONT C GRENIER L LEBRUN M TARDIF D GOURDE P BERGERON MG THIBAULT L LABRECQUE G
Citation: D. Beauchamp et al., TIME-RESTRICTED FEEDING SCHEDULES MODIFY TEMPORAL VARIATION OF GENTAMICIN EXPERIMENTAL NEPHROTOXICITY, Antimicrobial agents and chemotherapy, 41(7), 1997, pp. 1468-1474
ATTENUATION OF GENTAMICIN-INDUCED NEPHROTOXICITY IN RATS BY FLEROXACIN
Authors: BEAUCHAMP D LAURENT G GRENIER L GOURDE P ZANEN J HEUSONSTIENNON JA BERGERON MG
Citation: D. Beauchamp et al., ATTENUATION OF GENTAMICIN-INDUCED NEPHROTOXICITY IN RATS BY FLEROXACIN, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1237-1245
ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN AND FOSCARNET EACH GIVENALONE OR IN COMBINATION IN THE MURINE AIDS MODEL
Authors: OMAR RF HARVIE P GOURDE P DESORMEAUX A TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: Rf. Omar et al., ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN AND FOSCARNET EACH GIVENALONE OR IN COMBINATION IN THE MURINE AIDS MODEL, Toxicology and applied pharmacology, 143(1), 1997, pp. 140-151
ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN IN MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL
Authors: HARVIE P OMAR RF DUSSERRE N DESORMEAUX A GOURDE P TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: P. Harvie et al., ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN IN MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, Journal of acquired immune deficiency syndromes and human retrovirology, 12(5), 1996, pp. 451-461
TEMPORAL VARIATION IN NEPHROTOXICITY OF LOW-DOSES OF ISEPAMICIN IN RATS
Authors: YOSHIYAMA Y GRENIER L GOURDE P SIMARD M LIN LS MORIN NJ BERGERON MG LABRECQUE G BEAUCHAMP D
Citation: Y. Yoshiyama et al., TEMPORAL VARIATION IN NEPHROTOXICITY OF LOW-DOSES OF ISEPAMICIN IN RATS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 802-806
IN-VIVO TOXICITY OF FOSCARNET AND ZIDOVUDINE GIVEN ALONE OR IN COMBINATION
Authors: OMAR RF GOURDE P DESORMEAUX A TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: Rf. Omar et al., IN-VIVO TOXICITY OF FOSCARNET AND ZIDOVUDINE GIVEN ALONE OR IN COMBINATION, Toxicology and applied pharmacology, 139(2), 1996, pp. 324-332
NEPHROTOXICITY OF AMPHOTERICIN-B IN RATS - EFFECTS OF THE TIME OF ADMINISTRATION
Authors: LEBRUN M GRENIER L GOURDE P BERGERON MG LABRECQUE G BEAUCHAMP D
Citation: M. Lebrun et al., NEPHROTOXICITY OF AMPHOTERICIN-B IN RATS - EFFECTS OF THE TIME OF ADMINISTRATION, Life sciences, 58(11), 1996, pp. 869-876
RIBAVIRIN POTENTIATES THE EFFICACY AND TOXICITY OF 2',3'-DIDEOXYINOSINE IN THE MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL
Authors: HARVIE P OMAR RF DUSSERRE N LANSAC N DESORMEAUX A GOURDE P SIMARD M TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: P. Harvie et al., RIBAVIRIN POTENTIATES THE EFFICACY AND TOXICITY OF 2',3'-DIDEOXYINOSINE IN THE MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, The Journal of pharmacology and experimental therapeutics, 279(2), 1996, pp. 1009-1017
L-651,392, A POTENT LEUKOTRIENE INHIBITOR, CONTROLS INFLAMMATORY PROCESS IN ESCHERICHIA-COLI PYELONEPHRITIS
Authors: TARDIF M BEAUCHAMP D BERGERON Y LESSARD C GOURDE P BERGERON MG
Citation: M. Tardif et al., L-651,392, A POTENT LEUKOTRIENE INHIBITOR, CONTROLS INFLAMMATORY PROCESS IN ESCHERICHIA-COLI PYELONEPHRITIS, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1555-1560
DAPTOMYCIN MAY ATTENUATE EXPERIMENTAL TOBRAMYCIN NEPHROTOXICITY BY ELECTROSTATIC COMPLEXATION TO TOBRAMYCIN
Authors: COUTURE M SIMARD M GOURDE P LESSARD C GURNANI K LIN LS CARRIER D BERGERON MG BEAUCHAMP D
Citation: M. Couture et al., DAPTOMYCIN MAY ATTENUATE EXPERIMENTAL TOBRAMYCIN NEPHROTOXICITY BY ELECTROSTATIC COMPLEXATION TO TOBRAMYCIN, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 742-749
CEFTRIAXONE PROTECTS AGAINST TOBRAMYCIN NEPHROTOXICITY
Authors: BEAUCHAMP D THERIAULT G GRENIER L GOURDE P PERRON S BERGERON Y FONTAINE L BERGERON MG
Citation: D. Beauchamp et al., CEFTRIAXONE PROTECTS AGAINST TOBRAMYCIN NEPHROTOXICITY, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 750-756
SUBCELLULAR-DISTRIBUTION OF DAPTOMYCIN GIVEN ALONE OR WITH TOBRAMYCININ RENAL PROXIMAL TUBULAR CELLS
Authors: BEAUCHAMP D GOURDE P SIMARD M BERGERON MG
Citation: D. Beauchamp et al., SUBCELLULAR-DISTRIBUTION OF DAPTOMYCIN GIVEN ALONE OR WITH TOBRAMYCININ RENAL PROXIMAL TUBULAR CELLS, Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 189-194
NEPHROTOXICITY OF LOW-DOSES OF TOBRAMYCIN IN RATS - EFFECT OF THE TIME OF ADMINISTRATION
Authors: LIN LS GRENIER L THERIAULT G GOURDE P YOSHIYAMA Y BERGERON MG LABRECQUE G BEAUCHAMP D
Citation: Ls. Lin et al., NEPHROTOXICITY OF LOW-DOSES OF TOBRAMYCIN IN RATS - EFFECT OF THE TIME OF ADMINISTRATION, Life sciences, 55(3), 1994, pp. 169-177
Risultati: 1-15 |